Distinct medication-state modulation of motor-cortical low-beta power in tremor-dominant and postural instability/gait difficulty Parkinson’s disease: a source-space resting-state EEG study - Report - MDSpire

Distinct medication-state modulation of motor-cortical low-beta power in tremor-dominant and postural instability/gait difficulty Parkinson’s disease: a source-space resting-state EEG study

  • By

  • Hao Wang

  • Xiangyu Chen

  • Guoqing Wu

  • Xiaowei Du

  • Ganqin Du

  • June 25, 2026

  • 0 min

Share

Differential Effects of Medication on Motor-Cortical Low-Beta Activity in PD

Overview

This study investigates the modulation of motor-cortical low-beta activity in Parkinson's disease subtypes under medication states. It finds significant differences in low-beta power changes between tremor-dominant and postural instability/gait difficulty subtypes when transitioning from OFF to ON medication states, utilizing source-space EEG.

Background

Parkinson's disease (PD) presents with heterogeneous motor symptoms, notably the tremor-dominant (TD) and postural instability/gait difficulty (PIGD) subtypes. Understanding the electrophysiological differences between these subtypes is important. This study utilizes source-space EEG to explore these differences in a controlled medication state.

Data Highlights

GroupMedication StateLow-Beta Power Change (dB)
PIGDOFF to ON+1.26 (95% CI [0.48, 2.04])
TDOFF to ON-0.20 (95% CI [-1.02, 0.63])

Key Findings

  • Low-beta relative PSD in the primary motor cortex showed a significant group × state interaction (p = 0.016).
  • PIGD patients exhibited an increase in low-beta power from OFF to ON medication states.
  • TD patients showed little change in low-beta power across medication states.
  • Exploratory analyses indicated differences in high-beta ΔwPLI between cerebellar regions for subtypes (q = 0.028).
  • No significant network-level effects were identified through NBS.

Clinical Implications

The findings suggest that motor-cortical low-beta activity may serve as a biomarker for distinguishing between PD subtypes in clinical settings. Understanding these differences can inform tailored therapeutic approaches for managing motor symptoms in PD.

Conclusion

This study highlights distinct electrophysiological responses to medication in PD subtypes.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. MDS Position: Diagnosis of PD
  6. How to identify tremor dominant and postural instability/gait difficulty groups
  7. Modulation of subthalamic beta oscillations in Parkinson’s disease
  8. MDS Position: Diagnosis of PD
  9. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale - Stebbins - 2013 - Movement Disorders - Wiley Online Library
  10. Modulation of subthalamic beta oscillations by movement, dopamine, and deep brain stimulation in Parkinson’s disease | npj Parkinson's Disease

Original Source(s)

Related Content